Olympia and Wesley Pharmaceuticals are expanding their portfolios of longevity and preventative health products. Key launches include 'Circulate,' a single-dose IV premix containing arginine and taurine for blood flow support, and a new NAD+ formulation aimed at skin health and longevity. These releases are part of a broader strategy to provide 503(b)-compliant injectables and nutritional therapies to healthcare providers.